Pulmonx (LUNG) Total Current Liabilities (2019 - 2025)
Pulmonx (LUNG) posted quarterly Total Current Liabilities of $20.1 million for Q4 2025, down 17.92% year-over-year from $24.4 million in Q4 2024, and down 12.33% quarter-over-quarter from $22.9 million in Q3 2025.
Pulmonx (LUNG) Total Current Liabilities (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Total Current Liabilities for 7 consecutive years, with $20.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities fell 17.92% year-over-year to $20.1 million; the TTM figure through Dec 2025 stood at $20.1 million (down 17.92% YoY), while the FY2025 annual figure was $20.1 million, down 17.92% from the prior year.
- Total Current Liabilities eased to $20.1 million in Q4 2025 per LUNG's latest filing, from $22.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $24.9 million in Q1 2025 and bottomed at $14.0 million in Q1 2021.
- Historically, Total Current Liabilities has averaged $20.0 million across 5 years, with a median of $20.3 million in 2022.
- Annual changes were most pronounced in 2021 — Total Current Liabilities soared 46.41% — and 2025, when it fell 17.92%.
- Pulmonx's Total Current Liabilities stood at $17.6 million in 2021, then increased by 5.37% to $18.5 million in 2022, then increased by 25.23% to $23.2 million in 2023, then advanced by 5.53% to $24.4 million in 2024, then dropped by 17.92% to $20.1 million in 2025.
- Business Quant data shows LUNG's Total Current Liabilities at $20.1 million in Q4 2025, $22.9 million in Q3 2025, and $22.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Pulmonx | 97.63 Mn | 27.88 Mn | - | 20.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.06 Mn |
| Sep 30, 2025 | 22.88 Mn |
| Jun 30, 2025 | 22.45 Mn |
| Mar 31, 2025 | 24.95 Mn |
| Dec 31, 2024 | 24.44 Mn |
| Sep 30, 2024 | 18.30 Mn |
| Jun 30, 2024 | 16.30 Mn |
| Mar 31, 2024 | 21.29 Mn |
| Dec 31, 2023 | 23.16 Mn |
| Sep 30, 2023 | 20.49 Mn |
| Jun 30, 2023 | 19.52 Mn |
| Mar 31, 2023 | 17.08 Mn |
| Dec 31, 2022 | 18.49 Mn |
| Sep 30, 2022 | 21.69 Mn |
| Jun 30, 2022 | 20.45 Mn |
| Mar 31, 2022 | 17.72 Mn |
| Dec 31, 2021 | 17.55 Mn |
| Sep 30, 2021 | 22.22 Mn |
| Jun 30, 2021 | 16.33 Mn |
| Mar 31, 2021 | 14.02 Mn |